XML 66 R45.htm IDEA: XBRL DOCUMENT v3.25.0.1
Shareholders' capital (Tables)
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of Number of Common Shares
Number of common shares 
20242023
Common shares, beginning of year689,271,039 683,614,803 
Settlement of Purchase contracts (a(ii))
76,909,700 — 
Dividend reinvestment plan (a(i))
 4,370,289 
Exercise of share-based awards (b)
1,162,653 1,284,532 
Conversion of convertible debentures471 1,415 
Common shares, end of year767,343,863 689,271,039 
Schedule of Share-based Compensation Expense
For the year ended December 31, 2024, AQN recorded $18,388 (2023 - $10,508) in total share-based compensation expense as follows: 
20242023
Share options$658 $1,325 
Director deferred share units1,127949
Employee share purchase639897
Performance and restricted share units15,964 7,337 
Total share-based compensation$18,388 $10,508 
Schedule of Fair Value of Share Options Granted The following assumptions were used to determine the fair value of share options granted in 2023:
2023
Risk-free interest rate
3.4%
Expected volatility
26.8%
Expected dividend paid
8.6%
Expected life
5.5 years
Weighted average grant date fair value per option$1.04
Schedule of Stock Option Activity
Share option activity during the years is as follows: 
Number of
awards
Weighted
average
exercise
price
Weighted
average
remaining
contractual
term (years)
Balance, January 1, 20232,626,780 C$16.02 5.63
Granted1,368,744 10.76 7.24
Exercised— — — 
Forfeited(1,327,799)16.55 — 
Balance, December 31, 20232,667,725 C$14.71 5.18
Granted— — — 
Exercised— — — 
Forfeited(622,646)15.12 — 
Balance, December 31, 2024$2,045,079 C$14.93 3.95
Exercisable, December 31, 2024$1,873,957 C$15.34 3.73
Schedule of Performance Stock Units
A summary of the PSUs and RSUs is as follows: 
Number of awardsWeighted
average
grant-date
fair value
Weighted
average
remaining
contractual
term (years)
Aggregate
intrinsic
value
Balance, January 1, 20232,109,710 C$18.38 1.76C$18,608 
Granted, including dividends2,841,967 10.982.0225,329 
Exercised(922,883)18.7310,125 
Forfeited(451,047)15.073,771 
Balance, December 31, 20233,577,747 C$18.38 1.76C$29,777 
Granted, including dividends2,863,298 7.24 2.0420,025 
Exercised(416,659)16.66 3,421 
Forfeited(833,416)11.91 5,317 
Balance, December 31, 20245,190,970 C$18.38 1.43C$33,118 
Exercisable, December 31, 2024889,318 C$18.51  C$5,674 
Schedule of Shares Issued and Outstanding
The Company has the following Cumulative Rate Reset Preferred Shares, Series A (the "Series A Shares") and Cumulative Rate Reset Preferred Shares, Series D (the "Series D Shares") issued and outstanding as of December 31, 2024 and 2023:

Number of sharesPrice per shareCarrying amount C$Carrying amount $
Series A Shares
4,800,000 C$25.00C$116,546 $100,463 
Series D Shares
4,000,000 C$25.00C$97,259 $83,836 
$184,299